
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : SFA005
Therapeutic Area : Immunology
Study Phase : Preclinical
Sponsor : SFA Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership
Melior Discovery Announces Partnership with SFA on Grant Directed to COVID-19
Details : In this important effort to counter the effects of the COVID-19 virus SFA005 is expected to address the cytokine storm linked to Acute Respiratory Distress Syndrome (ARDS) experienced by patients infected with COVID-19.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
June 24, 2020
Lead Product(s) : SFA005
Therapeutic Area : Immunology
Highest Development Status : Preclinical
Sponsor : SFA Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership
